obexelimab
obexelimab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zenas BioPharma, Inc. (ZBIO) | Phase 2 |
Clinical Trials (1)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With IgG4-Related Disease (INDIGO)
Frequently asked questions
Who is developing obexelimab?
obexelimab is being developed by Zenas BioPharma, Inc..
How many clinical trials involve obexelimab?
BioSniper tracks 1 clinical trial involving obexelimab.
Get deeper analysis on obexelimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis